Literature DB >> 28132655

Defining Roles for Pharmacy Personnel in Disaster Response and Emergency Preparedness.

Mohammad Alkhalili1, Janice Ma2, Sylvain Grenier2.   

Abstract

Ongoing provision of pharmaceuticals and medical supplies is of key importance during and following a disaster or other emergency event. An effectively coordinated response involving locally available pharmacy personnel-drawing upon the efforts of licensed pharmacists and unlicensed support staff-can help to mitigate harms and alleviate hardship in a community after emergency events. However, pharmacists and their counterparts generally receive limited training in disaster medicine and emergency preparedness as part of their initial qualifications, even in countries with well-developed professional education programs. Pharmacy efforts have also traditionally focused on medical supply activities, more so than on general emergency preparedness. To facilitate future work between pharmacy personnel on an international level, our team undertook an extensive review of the published literature describing pharmacists' experiences in responding to or preparing for both natural and manmade disasters. In addition to identifying key activities that must be performed, we have developed a classification scheme for pharmacy personnel. We believe that this framework will enable pharmacy personnel working in diverse practice settings to identify and undertake essential actions that are necessary to ensure an effective emergency response and will promote better collaboration between pharmacy team members during actual disaster situations. (Disaster Med Public Health Preparedness. 2017;11:496-504).

Keywords:  capacity building; disaster planning; emergency preparedness; pharmacy; professional role

Mesh:

Year:  2017        PMID: 28132655     DOI: 10.1017/dmp.2016.172

Source DB:  PubMed          Journal:  Disaster Med Public Health Prep        ISSN: 1935-7893            Impact factor:   1.385


  8 in total

1.  The pharmacist's role in disaster research response.

Authors:  Christopher J Edwards; Aubrey Miller; J Perren Cobb; Brian L Erstad
Journal:  Am J Health Syst Pharm       Date:  2020-06-23       Impact factor: 2.637

2.  Community pharmacy cognitive services during the COVID-19 pandemic: A descriptive study of practices, precautions taken, perceived enablers and barriers and burnout.

Authors:  Betul Okuyan; Muhammed Yunus Bektay; Zehra Betul Kingir; Dilsad Save; Mesut Sancar
Journal:  Int J Clin Pract       Date:  2021-09-23       Impact factor: 3.149

Review 3.  Pharmacists' roles in emergency and disasters: COVID-19 as an example.

Authors:  Wejdan Aburas; Thamir M Alshammari
Journal:  Saudi Pharm J       Date:  2020-11-21       Impact factor: 4.330

4.  Participation in emergency preparedness and response: a national survey of pharmacists and pharmacist extenders.

Authors:  Yi Zhao; Kavon Diggs; David Ha; Hannah Fish; John Beckner; Salisa C Westrick
Journal:  J Am Pharm Assoc (2003)       Date:  2021-06-08

5.  Cross-sectional questionnaire study of the experiences of community pharmacists in Northern Ireland during the early phases of the COVID-19 pandemic: preparation, experience and response.

Authors:  Susan M Patterson; Cathal Cadogan; Heather E Barry; Kathleen E Bennett; Carmel Hughes
Journal:  BMJ Open       Date:  2022-09-22       Impact factor: 3.006

Review 6.  Rapid realist review of the role of community pharmacy in the public health response to COVID-19.

Authors:  Ian Maidment; Emma Young; Maura MacPhee; Andrew Booth; Hadar Zaman; Juanita Breen; Andrea Hilton; Tony Kelly; Geoff Wong
Journal:  BMJ Open       Date:  2021-06-16       Impact factor: 2.692

7.  COVID-19 pandemic planning, response, and lessons learned at a community hospital.

Authors:  Daryl S Schiller; Magda Fulman; Jennifer Champagne; Nirvana Awad
Journal:  Am J Health Syst Pharm       Date:  2020-08-20       Impact factor: 2.980

8.  Perspectives from the frontline: A pharmacy department's response to the COVID-19 pandemic.

Authors:  Curtis D Collins; Nina West; David M Sudekum; Jason P Hecht
Journal:  Am J Health Syst Pharm       Date:  2020-08-20       Impact factor: 2.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.